Alpha Tribe
FeedCompaniesAgentsSubscribe

Filter announcements

  • All
  • Important
  • Results
  • Board Meeting
  • New Orders
  • QIP/Rights/Pref.
  • PPTs
  • JV/Acquisition
  • Insider Trade
  • Dividend/Bonus
  • Credit Ratings
  • Updates
  • Pledging
  • Investor Meet
  • Others

Download our app

Best experience on mobile

Get it on Google PlayDownload on the App Store

Join 5K+ users on Alpha Tribe

Loading...
ER

Evoq Remedies Ltd

543500·Commercial Services & Supplies

EVOQ Remedies Ltd is engaged in the trading of pharmaceuticals formulation and allied productsBusiness Overview: Company is in the business of marketing, trading, and distribution of a wide range of pharmaceutical formulation products. Apart from this, the company also deals in trading of active pharmaceutical ingredients, Nutraceutical, Ayurvedic, and Herbal...

45Announcements
11-06-2026Last filed
0Last 90 days
evoqremedies.com

What Evoq files

  • Others14
  • Important12
  • Updates8
  • Board Meeting6
  • Insider Trading4
  • Dividend/Bonus1
11-06-2026 · 05:15 pm

Evoq Remedies Limited is now under Corporate Insolvency Resolution Process. The National Company Law Tribunal admitted an application filed by M/s. Harbhole Agrotech, an operational creditor, over an unpaid advance of 1.95 Cr. This advance was for goods (FSG Castor Oil) that were neither supplied nor refunded. The NCLT has...

Read the full announcement→
PDF
10-06-2026 · 06:11 pm

Evoq Remedies Limited CIN: L46209GJ2010PLC059692 Regd. Office: A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India – 380 060 E-mail: evoqremedies@gmail.com Website: www.evoqremedies.com Date: 10th June, 2026 To, BSE Limited Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai – 400 001 Dear Sir / Ma’am, Sub:...

Read the full announcement→
PDF
30-05-2026 · 07:44 pm

Evoq Remedies has filed its financial results for the half-year and year with a qualified audit opinion, citing significant doubt about its ability to continue as a going concern. Key concerns include unapproved related-party loans of 6.70 Cr, unconfirmed debtors (3.85 Cr) and supplier advances (12.51 Cr), and unpaid income...

Read the full announcement→
PDF
30-05-2026 · 07:42 pm

Evoq Remedies' Board approved the financial results for the half-year and year ended March 31, 2026, and appointed M/s. Jay Pandya & Associates as Secretarial Auditor for FY 2025-26. However, auditors issued a qualified opinion, citing material uncertainty about the company's ability to continue as a going concern. This is...

Read the full announcement→
PDF
30-05-2026 · 07:37 pm

Board of Directors has approved Audited Financials results for the Halh year and year ended on 31st March, 2026

Read the full announcement→
PDF